|
Aarti Pharmalabs Ltd share price inched up 0.54% to Rs 924.7 after the company's net profit softened by 6.13% to Rs 71.47 crore, while revenue from operations increased 13.93% to Rs 610.45 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, rising 5.84%. It has improved by 3.49% over last one week and moved up slightly by 6.26% in last one month while the market capitalization of Aarti Pharmalabs Ltd has eased by 0.41% and 8.51% in the same period respectively.
Profit before tax (PBT) of Aarti Pharmalabs Ltd stood at Rs 94.99 crore in Q2 FY27, rallying 145.52% year-on-year, and declining 6.01% quarter-on-quarter. EBITDA came in at Rs 135 crore, expanding by 80.38% YoY and slipping 0.72% sequentially.
Total expenses increased by 17.71% to Rs 505.82 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 334.88 crore, witnessing a sharp rise of 32.96% YoY, while employee benefits expense was at Rs 54.55 crore, registering a growth of 8.41% YoY.
For FY26, revenue from operations contracted by 13.98% to Rs 1819.44 crore, while net profit tanked by 35.86% to Rs 174.71 crore, compared to previous FY. EBITDA surged by 47069% to Rs 359.46 crore, and PBT collapsed by 35.42% to Rs 232.92 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 261.93 crore in FY26, as against Rs 330.14 crore in FY25.
Aarti Pharmalabs Ltd soared by 20.08% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.37% during the same period.
|